|
|
 |
|
Viewing report
|
|
|
|
Biogenerics - Global Strategic Business Report
Global Industry Analysts, Inc., July 2006, Pages: 187
This report analyzes the worldwide markets for Biogenerics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2007 through 2013. The report profiles 42 companies including many key and niche players worldwide such as Biocon Limited, BioPartners, BioGeneriX AG, Cangene Corporation, Cipla Ltd., Dr. Reddys Laboratories, GeneMedix, LG Life Sciences, Pliva d.d., Ranbaxy Laboratories Limited, Sandoz International GmbH, Stada Arzneimittel, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, and Wockhardt Limited.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
A Guide to Biosimilars, Biogenerics and Follow-On Biologics
Pharmaceuticals - Global Outlook
Biogenerics 2005: A New Level Of Complexity
Toward a Biogenerics Market: The Regulatory Conundrum
Biogenerics: Challenges and Promise
Competitor Analysis: Biogenerics & Therapeutic Proteins
Biogenerics: Drivers and Resistors of Market Development
Biosimilars, Biogenerics and Follow-On Biologics
China Telecom Operator Capex Annual Report 2004-2005
System-On-A-Chip (SOC) - Global Strategic Business Report
The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players
Strategic Analysis of the World Biogenerics Market
|
|
|
|
